These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 666968)

  • 1. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 2. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficiency and side effects of adriamycin-cyclophosphamide therapy compared to a triple combination of cyclophosphamide, methotrexate and 5-fluoro-uracil].
    Weymar P; Schulz KD; Noldus B; Schmidt-Rhode P
    Arch Gynecol; 1979 Jul; 228(1-4):445-6. PubMed ID: 485425
    [No Abstract]   [Full Text] [Related]  

  • 6. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
    Umsawasdi T; Nilprabhassorn P
    J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC; Sylvester R; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy for breast cancer.
    Allegra JC; Lippman ME
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of breast cancer.
    Mitchell MS
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S; Krasnokuki D; Hochman A; Brufman G
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA
    Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of doxorubicin (adriamycin) in disseminated forms of breast cancer].
    Trofimova NB; Gorbunova VA
    Antibiotiki; 1983 Aug; 28(8):625-8. PubMed ID: 6638976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop; 1975 Jul 10-20; 51(31-34):2119-21. PubMed ID: 170687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles].
    Sismondi P; Zola P; Galletto L; De Giovanni D; Giardina G
    Minerva Ginecol; 1979; 31(7-8):563-8. PubMed ID: 481814
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1626-30. PubMed ID: 7030686
    [No Abstract]   [Full Text] [Related]  

  • 19. The polychemotherapeutic treatment of advanced breast cancer.
    Brown I; Arthur K; Banks AJ; Bond WH; Chowdhury MS; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ward HW
    Clin Oncol; 1977 Jun; 3(2):183-9. PubMed ID: 872472
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of a prospective clinical trial comparing two cytotoxic regimes containing adriamycin in women with advanced breast cancer.
    Priestman TJ
    Clin Oncol; 1975 Sep; 1(3):207-11. PubMed ID: 1212828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.